The North America Lipid Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).
Microencapsulation technology improvements in emerging economies are likely to support the lipid nutrition market share due to its multiple benefits in applications such as medicines, functional foods, and animal nutrition, among others. Since the technology encases food in a shell, key nutrients are protected. It also allows for easy processing and packaging because it can turn liquid ingredients into powder. The price trend of nutritional lipids is mostly determined by rising raw material costs, such as fish oil and flaxseed oil. The many benefits of lipid supplements to arthritis, diabetes, cancer patients is what drives the market.
Bile acids emulsify lipids in the stomach. Bile acids are generated in the hepatocyte from cholesterol and transferred to the biliary canaliculus via an adenosine triphosphate (ATP)-dependent transport mechanism. About half of the bile acids reach the gallbladder as they move down the biliary duct.
According to a report published in the Pharmaceutical Journal in December 2019, the United States Food and Drug Administration (FDA) has approved the omega-3 fatty acid icosapent ethyl as a collateral healing treatment to reduce the risk of cardiovascular events in mature adults with high triglyceride levels. These types of factors are propelling the nutritional lipids market forward in the North American region.
In the United States, heart disease is the top cause of mortality for men, women, and people of most racial and ethnic groups In the United States, one person dies from some cardiovascular disease every 36 seconds. Heart disease kills over 659,000 people in the United States each year, accounting for one out of every four deaths. Between 2016 and 2017, the United States spent $363 billion on heart disease. This covers the costs of healthcare services, medications, and lost productivity as a result of mortality.
The US market dominated the North America Lipid Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,615.1 Million by 2028. The Canada market is anticipated to grow at a CAGR of 10% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 9.1% during (2022 - 2028).
Based on Application, the market is segmented into Food & Beverages, Pharmaceuticals, Nutrition & Supplements, and Others. Based on Source, the market is segmented into Plant-based and Animal-based. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Lipid Market is Estimated to reach $12.8 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser Group PLC, Kerry Group PLC, Clover Corporation Limited, Croda International PLC, FMC Corporation, Cargill Corporation, and Nordic Naturals, Inc.
By Application
By Source
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 